These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10806734)

  • 1. [The clinical evaluation of endometrial carcinoma following irradiation for cervical cancer].
    Sheng X; Sun J; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):553-5. PubMed ID: 10806734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
    Han SW; He B; Tang QP
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis.
    Hellström AC; Sigurjonson T; Pettersson F
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):152-7. PubMed ID: 11167211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignancy of the uterine body after radiotherapy for carcinoma of uterine cervix--report of 12 cases].
    Yu GR
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):361-3. PubMed ID: 3004856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital carcinoma after radiotherapy for carcinoma of the cervix. Report of two cases.
    Hou XH; Qian HN
    Chin Med J (Engl); 1991 Apr; 104(4):350-2. PubMed ID: 1648467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
    Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial carcinoma occurred after irradiation therapy for squamous cell carcinoma of the uterine cervix].
    Sato N; Tsunoda H; Oki A; Shigemitsu S; Sasaki J; Nishida M; Kubo T
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):75-8. PubMed ID: 7844459
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma following irradiation for cervical cancer: a case report.
    Toongsuwan S; Suvonnakote T; Varthananusara C
    J Med Assoc Thai; 1980 Jul; 63(7):421-3. PubMed ID: 7410989
    [No Abstract]   [Full Text] [Related]  

  • 18. The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.
    Park TW; Zivanovic O; Theuerkauf I; Dürkop B; Hernando JJ; Simon M; Büttner R; Kuhn W
    Int J Oncol; 2004 Apr; 24(4):829-36. PubMed ID: 15010819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.
    Pertschuk LP; Masood S; Simone J; Feldman JG; Fruchter RG; Axiotis CA; Greene GL
    Gynecol Oncol; 1996 Oct; 63(1):28-33. PubMed ID: 8898164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.